From Seekingalpha · SA Transcripts · · 40s
Veradermics Shares Positive Hair Loss Study Results
Veradermics reports strong Phase III trial results for male hair loss treatment.
In brief
Veradermics reports strong Phase III trial results for male hair loss treatment. Veradermics (MANE) achieved positive top line results from Phase III Study 304 of VDPHL01 for male pattern hair loss. Originally reported by Seekingalpha.
Veradermics Shares Positive Hair Loss Study Results
Veradermics (MANE) reported positive top line results from Phase III Study 304 of VDPHL01 for male pattern hair loss.
Company Leadership Present
Dominic Carrano, CFO & Treasurer, Reid Waldman, CEO & Director, and Mark Neumann, Chief Commercial & Strategy Officer joined the call.
Clinical Perspective Coming
Dr. Michael Payette, Founder of Central Connecticut Dermatology, will provide clinical insights on patient impact.
What it means
Veradermics (MANE) achieved positive top line results from Phase III Study 304 of VDPHL01 for male pattern hair loss.
